Morphle Labs Raises $5 Mn To Automate Tissue, Blood Diagnostics

Cancer diagnosis startup Morphle Labs has raised $5 Mn (about INR 44.6 Cr) in its Series A funding round from Inflexor Ventures to enhance tech capabilities and expand global footprint.

The Bengaluru-based company, which also has operations in the US, is planning to deploy the freshly raised capital in scaling manufacturing for its flagship products RoboTome and MorphoLens.